Embryonic stem cells (ESCs) and other primitive stem cells of mice have been known for more than 30 years to potently block retrovirus replication 1 . Infection of ESCs by the murine leukaemia viruses (MLVs) results in the normal establishment of integrated proviral DNA, but this DNA is then transcriptionally silenced, preventing further viral spread. The repression is largely mediated by transacting factors that recognize a conserved sequence element termed the primer binding site, an 18-base pair sequence complementary to the 39 end of a cellular transfer RNA 2-6 . A specific tRNA is annealed to the primer binding site sequence of the viral genomic RNA, and is used to prime DNA synthesis 7 . This same sequence in the context of the integrated proviral DNA is targeted for silencing in ESCs. We have recently shown that a large protein complex binding to the primer binding site in ESCs contains TRIM28 (refs 8, 9), a wellcharacterized transcriptional co-repressor 10-12 . An important question remains as to the identity of the factor that directly recognizes integrated retroviral DNAs and recruits TRIM28 to mediate their specific silencing. Here we identify the zinc finger protein ZFP809 as the recognition molecule that bridges the integrated proviral DNA and TRIM28. We show that expression of ZFP809 is sufficient to render even differentiated cells highly resistant to MLV infection. Furthermore, we demonstrate that ZFP809 is able to potently block transcription from DNA constructs of human T-cell lymphotropic virus-1 (HTLV-1), which use the same primer tRNA. These results identify ZFP809 as a DNA-binding factor that specifically recognizes a large subset of mammalian retroviruses and retroelements, targeting them for transcriptional silencing. We propose that ZFP809 evolved as a stem-cell-specific retroviral restriction factor, and therefore constitutes a new component of the intrinsic immune system of stem cells.
Embryonic stem cells (ESCs) and other primitive stem cells of mice have been known for more than 30 years to potently block retrovirus replication 1 . Infection of ESCs by the murine leukaemia viruses (MLVs) results in the normal establishment of integrated proviral DNA, but this DNA is then transcriptionally silenced, preventing further viral spread. The repression is largely mediated by transacting factors that recognize a conserved sequence element termed the primer binding site, an 18-base pair sequence complementary to the 39 end of a cellular transfer RNA [2] [3] [4] [5] [6] . A specific tRNA is annealed to the primer binding site sequence of the viral genomic RNA, and is used to prime DNA synthesis 7 . This same sequence in the context of the integrated proviral DNA is targeted for silencing in ESCs. We have recently shown that a large protein complex binding to the primer binding site in ESCs contains TRIM28 (refs 8, 9) , a wellcharacterized transcriptional co-repressor [10] [11] [12] . An important question remains as to the identity of the factor that directly recognizes integrated retroviral DNAs and recruits TRIM28 to mediate their specific silencing. Here we identify the zinc finger protein ZFP809 as the recognition molecule that bridges the integrated proviral DNA and TRIM28. We show that expression of ZFP809 is sufficient to render even differentiated cells highly resistant to MLV infection. Furthermore, we demonstrate that ZFP809 is able to potently block transcription from DNA constructs of human T-cell lymphotropic virus-1 (HTLV-1), which use the same primer tRNA. These results identify ZFP809 as a DNA-binding factor that specifically recognizes a large subset of mammalian retroviruses and retroelements, targeting them for transcriptional silencing. We propose that ZFP809 evolved as a stem-cell-specific retroviral restriction factor, and therefore constitutes a new component of the intrinsic immune system of stem cells.
Moloney MLV, a prototypical simple retrovirus, contains a primer binding site (PBS) complementary to proline tRNA (PBS Pro ), and is potently restricted by ESCs and embryonic carcinoma cells (ECCs) in a PBS-dependent mechanism. A single base-pair change known as the B2 mutation (PBS B2 ) is sufficient to prevent binding of the ESC silencing factors and so abrogate this restriction 2 . To identify the DNA-binding component of the complex, we used an ultravioletcrosslinking approach. We first confirmed that a BrdU-substituted radiolabelled DNA probe corresponding to PBS Pro retained the correct specificity for the PBS silencing complex ( Supplementary  Fig. 1 ). We then incubated this DNA probe with nuclear extracts of the F9 ECC cell line, treated the samples with ultraviolet light to form covalent protein-DNA crosslinks, and resolved the complexes by SDS-PAGE under denaturing conditions. A crosslinked species migrating at the position of an approximately 45-kDa protein was observed. This species was not detected when the experiment was performed using a mutant PBS B2 probe, or when a large excess of unlabelled (cold) PBS Pro probe was added to the reaction (Fig. 1a ). The addition of 15 base pairs (bp) to the PBS Pro probe caused the species to migrate at a position corresponding to a mass of ,55 kDa. To confirm that the 45-kDa species was a true component of the PBS binding complex, we showed that this species co-immunoprecipitated with TRIM28, a confirmed subunit of the silencing complex ( Fig. 1b) . These experiments suggested that a 45-kDa protein was in close contact with DNA and thus was a strong candidate for the sequence-specific recognition factor.
To determine the identity of this protein, we partially purified the PBS silencing complex from F9 ECC nuclear extracts 8 and immunoprecipitated the complex with a TRIM28-specific antibody (Fig. 1c ). This immunoprecipitated material was resolved by SDS-PAGE, and bands corresponding to the 45-kDa species were excised and characterized by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) ( Fig. 1d and Supplementary Table 1 ). Of the proteins identified, the three most likely candidates for DNA-binding factors were L1TD1, ZFP809 and ZFP124. L1TD1 has sequence similarity to the products of the ORF1 gene of LINE-1 retrotransposons, proteins known to bind DNA 13 . ZFP809 and ZFP124 are both members of the family of Kruppel-associated box (KRAB)-containing zinc finger proteins, which bind DNA 14 and interact with TRIM28 via their KRAB domain 15, 16 . To determine which of these candidates has the requisite DNA-binding specificity, we expressed all three in Escherichia coli as recombinant proteins fused to glutathione-S-transferase (GST) 17 , and tested lysates in electrophoretic mobility shift assays (EMSAs) with 28-bp probes corresponding to either PBS Pro or PBS B2 ( Fig. 2a and Supplementary Fig. 2 ). Of the three candidates only ZFP809 bound to the wild-type PBS Pro sequence (but not to PBS B2 ), strongly suggesting that ZFP809 was the DNA recognition component of the PBS silencing complex ( Fig. 2a ). To determine whether ZFP809 was able to bind simultaneously to PBS Pro DNA and TRIM28, we added increasing amounts of recombinant GST-tagged TRIM28 to EMSA reactions containing ZFP809 and either the PBS Pro or the PBS B2 probe (Fig. 2b ). The addition of TRIM28 markedly supershifted the ZFP809-PBS Pro probe complex, whereas the PBS B2 probe remained unbound (Fig. 2b ). The addition of TRIM28 markedly increased the yield of shifted probe, suggesting that it stabilized the complex or increased the affinity of ZFP809 for the PBS Pro probe. Furthermore, the PBS binding complex that formed in the presence of recombinant TRIM28 and ZFP809 proteins showed virtually identical migration to the PBS complex formed in nuclear extracts from ECCs, suggesting that these two components alone are sufficient to reconstitute the minimal PBS silencing complex ( Fig. 2b) . Moreover, the DNA-binding specificity of this recombinant reconstituted complex was found to be virtually indistinguishable from the native complex ( Supplementary Fig. 3) .
These experiments strongly suggested that ZFP809 was the DNA recognition component of the PBS silencing complex and, because TRIM28 is ubiquitous and present at high concentrations, also indicated that ZFP809 was probably the critical limiting component in ESCs and thus sufficient to induce virus resistance. We therefore addressed whether expression of this protein in a permissive cell line could render it resistant to MLV or other viruses using a PBS specific for proline tRNA. Initial attempts to generate 293A cell lines stably expressing full-length ZFP809 were unsuccessful and most often yielded clones with 39 deletions, suggesting that the carboxy-terminal 50 residues are toxic in non-stem cells. Subsequent experiments were performed with constructs expressing the ZFP809 protein truncated at amino acid 353 (ZFP809(1-353)), which showed minimal toxicity and was expected to retain its silencing functionality as it included both DNA-binding and TRIM28-binding domains ( Supplementary Fig. 4 ). 293A cells stably expressing ZFP809(1-353) with an amino-terminal Flag tag were generated and individual clones were screened for ZFP809(1-353) expression ( Supplementary Fig. 5b ). Clones expressing the empty vector were constructed in parallel. Three representative cloned lines were selected for further study: clone 5, which expressed representative levels of ZFP809(1-353); clone 9, which had been transformed with the ZFP809(1-353) DNA but failed to express ZFP809; and control clone 1, which contained the empty vector ( Fig. 3a and Supplementary Fig.  5b ). The cell lines were all confirmed to retain normal TRIM28 expression ( Fig. 3a) . Nuclear extracts were prepared and tested for the presence of the silencing complex by EMSAs. The line expressing ZFP809(1-353) exhibited a strong PBS Pro binding activity (Fig. 3b ). This reconstituted PBS silencing complex showed the same specificity as the native ECC complex and did not bind to the PBS B2 probe (Fig. 3b ). The shifted complex produced by expression of ZFP809(1-353) in 293A cells was shown to contain both endogenous TRIM28 and exogenous Flag-tagged ZFP809(1-353), as judged by supershifts with anti-TRIM28 and anti-Flag antibodies. The interaction between ZFP809 and TRIM28 in vivo was confirmed by co-immunoprecipitation in clone 5 cells ( Fig. 3c) .
To test whether reconstitution of the minimal PBS silencing complex was sufficient to induce silencing of MLV in a PBS-dependent manner, we used two MLV reporter constructs that were identical except for a single base-pair change in the PBS sequence. MLV particles pseudotyped by the VSV G protein, transducing the puromycinresistance gene, and using either PBS Pro or PBS B2 , were generated. The infectivity of these two virus preparations was determined by colony formation assays after infection of clone 5, and the controls consisting of control clone 1, clone 9 and the parental 293A cell lines. The ratio of infectivity of the PBS B2 MLV to that of the PBS Pro MLV in a given cell line is a measure of the level of PBS-mediated silencing, after normalizing the ratio for the parental cell line to 1. The control cell lines (control clone 1 and clone 9) had a ratio close to 1, indicating that they exhibited no PBS-mediated restriction. In contrast, clone 5 demonstrated potent PBS-mediated silencing, manifesting as a ratio of ,23fold ( Fig. 4a ). Analysis of other clones expressing ZFP809 showed that all exhibited potent PBS-mediated silencing (Supplementary Fig. 5a ). Thus, the expression of ZFP809(1-353) was sufficient to render a differentiated cell resistant to transduction by PBS Pro -using retroviral vectors. To investigate whether ZFP809 silences retroviral expression by binding directly to the integrated provirus, leading to the recruitment of TRIM28, we performed chromatin immunoprecipitations on lysates of clone 5 cells infected with either a restricted (PBS Pro ) or an unrestricted variant PBS corresponding to a glutamine tRNA (PBS Gln ) MLV ( Supplementary Fig. 6 ). We found that both ZFP809 and TRIM28 are markedly enriched at PBS Pro proviral sites ( Supplementary Fig. 6 ).
To assess whether ZFP809 could also reduce virus replication after authentic retrovirus infection we generated amphotropic MLV virus constructs containing either the restricted PBS Pro or the unrestricted PBS Gln . These viruses were used separately to infect the clone 5 and control clone 1 and clone 9 cell lines at a low multiplicity of infection, and the productive spread of the virus was monitored by measurement of reverse transcriptase activity in the culture media. The amphotropic virus using the wild-type PBS Pro could replicate in the control clone 1 and clone 9 cell lines, but was completely blocked in the clone 5 cell line (Fig. 4b) . The amphotropic MLV using PBS Gln was able to spread in all the cell lines.
To investigate whether ZFP809 expression is required for PBSmediated restriction in embryonic cells, ZFP809 expression was attenuated in F9 ECCs by RNA interference (RNAi). Substantial knockdown of ZFP809 correlated with a complete relief of PBSmediated restriction (pools 8, 9 and 12) ( Supplementary Fig. 7) . Messenger RNA analysis also showed lower expression of Zfp809 in non-restrictive NIH3T3 cells when compared to restrictive ESCs or F9 cells, consistent with the hypothesis that that there is a threshold level of ZFP809 required for PBS-mediated restriction (Supplementary Fig. 7) .
Having shown that MLV is potently restricted by ZFP809, we wished to determine whether the human pathogen HTLV-1, which also uses a PBS Pro , would also be restricted. A complication to this question is that unlike MLV, HTLV-1 expresses the accessory protein Tax, which recruits co-activators to the long terminal repeat (LTR) and stimulates transcription 18, 19 . It is therefore conceivable that Taxmediated stimulation of transcription from the LTR might overcome the block induced by ZFP809. To score for transcriptional silencing, we used an HTLV-1 LTR firefly luciferase reporter construct cotransfected with increasing amounts of a Tax-expressing plasmid, and with a thymidine kinase (TK)-Renilla luciferase control plasmid (for normalization) into clone 1, clone 9 and clone 5 cell lines (Fig. 4c) . The HIV-1 LTR (which does not contain a PBS Pro ) and the coexpression of the Tat transactivator protein were also tested, as a negative control (Fig. 4c ). In the case of basal transcription in the absence of Tax, the HTLV-1 LTR reporter construct was silenced 8-fold in clone 5 when compared to control clone 1, and with increasing amounts of Tax this fold silencing was increased, with clone 5 having on average a 14-fold lower LTR activity when compared with control clone 1 (Fig. 4c) . These results demonstrate that the HTLV-1 LTR is restricted, and that Tax expression does not abrogate ZFP809mediated restriction. To demonstrate that ZFP809-mediated restriction requires TRIM28, its levels were stably reduced in clone 5 by RNAi ( Supplementary Fig. 8 ). TRIM28 knockdown resulted in a decrease in PBS binding activity in clone 5 nuclear extracts and a reduction in HTLV-1 LTR restriction in these cells ( Supplementary  Fig. 8 ). We note that TRIM28 knockdown in clone 5 cells also led to a decrease in ZFP809 levels, suggesting that ZFP809 protein stability is reliant on formation of the TRIM28-ZFP809 complex ( Supplementary Fig. 8 ).
These findings indicate that ZFP809 is the critical DNA-binding factor in ESCs that recognizes integrated PBS Pro -using retroviral DNAs and silences them through the recruitment of TRIM28. We have shown that viruses using the distinctive Lys1,2 tRNA are also silenced in stem cells in a TRIM28-dependent manner 20 , and thus a factor must exist that recognizes this distinctive PBS. We speculate that ZFP809 represents the first in a class of PBS-specific retroviral restriction factors that all act through the recruitment of TRIM28 to different PBS elements to silence integrated retroviruses and thereby act as components of a stem-cell-specific intrinsic immunity.
METHODS SUMMARY
EMSA. Double-stranded DNA probes were 59 end-labelled using [c-33 P]-ATP. Binding reactions were performed using modified Thornell binding buffer 8 (25 mM HEPES, pH 7.9, 1 mM EDTA, 10% (v/v) glycerol, 5 mM dithiothreitol, 25 ng poly(dI-dC) per ml, 5 mM NaCl, 5 mM KCl, 3 mM MgCl 2 and 0.1 mM ZnCl 2 ). Probes (50,000 c.p.m.) were incubated with nuclear extract for 25 min at 30 uC in a total volume of 20 ml. For supershifts and cold DNA competitions, antibody/cold DNA was added at same time as probe. Binding reactions were analysed by electrophoresis on 4% native polyacrylamide gels 8 . Ultraviolet crosslinking. Proteins in F9 nuclear extracts were resuspended in modified Thornell binding buffer 8 and 150,000 c.p.m. 33 P-labelled probe was added to each 50 ml reaction. Samples were then exposed to 302 nm ultraviolet light for 45 min using a transilluminator (VWR). Competitions were performed with the addition of 100 pmol of unlabelled probe per reaction. Co-immunoprecipitations. Ten million clone 5 cells were lysed in 750 ml IPH buffer 21 (150 mM NaCl, 50 mM Tris-HCl, pH 8, 0.5% Nonidet P-40, 5 mM MgCl 2 , 1 mM CaCl 2 , 0.5 mM EDTA and protease inhibitors (Complete Protease Inhibitors, Roche)). The lysates were then treated with 100 U DNase (Roche) for 24 h at 4 uC. Ethidium bromide was subsequently added to lysates (50 mg ml 21 ) and co-immunoprecipitations were performed using 5 mg of antibody and a mixture of 20 ml protein A and 20 ml protein G Dynabeads (Invitrogen). Retroviral transduction assays. Virus stocks were collected as previously described 8 . Retroviral preparations were then serially diluted (for titre determination), and added to F9, NIH3T3 or 293A cells (seeded at 3.5 3 10 3 (F9) and 2 3 10 3 (NIH3T3 and 293A) cells per cm 2 the day before transduction) in the presence of 8 mg of Polybrene per ml. G418 or puromycin-containing selective media was added 24-48 h after infection and colonies were counted 14 days after selection. LTR reporter assays. 293A cells were seeded at 7,000 cells per well in a 96-well plate and were transfected using Fugene 6 (Roche) with 20 ng HTLV-1 LTR or HIV-1 LTR firefly luciferase reporter plasmid, 5 ng of a TK promoter Renilla luciferase control plasmid (phRL-TK, Promega), and a Tax-or Tat-expressing vector. Luciferase activity was assayed 48 h after infection using dual-luciferase reporter assay (Promega).
